Table 2.

Distribution of key cardiovascular risk factors among MASALA participants who would be considered statin-recommended using SA ethnicity as a risk enhancing factor.

	Intermediate + high		Borderline + intermediate + high
	estimated ASCVD risk*		estimated ASCVD risk*
	Overall	CAC=0	Overall	CAC=0
Number (%)	162 (100)	44 (27.2)	234 (100)	83 (35.4)
Age, years	65 (61, 69)	63 (59, 68)	62 (57, 67)	60 (54, 66)
Women	34 (21.0)	12 (27.3)	52 (22.2)	21 (25.3)
Abdominal obesity†	128 (79.0)	36 (81.8)	186 (79.5)	65 (78.3)
Fasting glucose, mg/dL	94 (89, 101)	93 (88, 98)	94 (89, 101)	92 (87, 99)
HbA1c, %	5.7 (5.5, 5.9)	5.7 (5.5, 5.9)	5.7 (5.5, 5.9)	5.7 (5.5, 5.9)
Prediabetes‡	107 (66.1)	25 (59.1)	160 (68.4)	57 (68.8)
Total cholesterol, mg/dL	195 (33)	189 (26)	195 (32)	192 (27)
HDL cholesterol, mg/dL	45 (39, 54)	43 (40, 53)	44 (37, 53)	43 (38, 51)
Triglycerides, mg/dL	118 (88, 157)	142 (98, 168)	123 (91, 164)	135 (97, 172)
Hypertension medication use	68 (42.0)	16 (36.4)	81 (34.6)	22 (26.5)

^*Estimated using the Pooled Cohort Equations for non-Hispanic Whites.

^†Waist circumference >80 cm for women or >90 cm for men.

^‡Glucose levels 100 – 125 mg/dL or HbA1c ≥5.7% and <6.5%.

Categorical variables are presented as number (%), and continuous variables are presented as mean (standard deviation) or median (interquartile range). ASCVD = atherosclerotic cardiovascular disease events; HbA1c = glycosylated hemoglobin; HDL = high-density lipoprotein; MASALA = Mediators of Atherosclerosis in South Asians Living in America